BioSpace News Archive

Acessa Health Inc., developer of the Acessa System®, announced today that its laparoscopic radiofrequency ablation technology was featured at the 47th American Association of Gynecologic Laparoscopists (AAGL) Global Congress on Minimally Invasive Gynecologic Surgery (MIGS).

NeuroRx, a clinical stage biopharma company focused on the development of Rapid Acting Antidepressants (RAADs) that target the brain’s NMDA receptor, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for development of NRX-101

Atlantic therapeutics a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, announced today that the U.S. Food and Drug Administration has granted a DeNovo clearance for its INNOVO therapy device

Cesca Therapeutics announced that its device subsidiary, ThermoGenesis® Corp., has filed a Device Master File (MAF) with the U.S. Food and Drug Administration (FDA) for its X-LAB® automated cell processing device.

National consulting firm brings expertise to Medicare, Medicaid and Dual-Eligible Health Plans and their members

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company has been awarded a contract for iQ-Check real-time PCR pathogen detection test kits and the iQ-Check Prep Automation System from the United States Department of Agriculture’s Food Safety and Inspection Service (USDA FSIS).

F1 Oncology, Inc., today announced that its international affiliate, EXUMA Biotechnology Hong Kong, has formed Shanghai EXUMA Biotechnology Co., Ltd., a wholly foreign-owned enterprise (WFOE), to acquire all rights to novel chimeric antigen receptor T (CAR-T) cell therapy and manufacturing assets in Shanghai and Shenzhen

Data presented at the Annual Scientific Sessions of the American Heart Association in Chicago, IL on November 12, 2018.

Candela Corporation announces that the Profound® treatment has been named “New Treatment of the Year” by The Global Aesthetic Awards.

Statement Calls on Schools to Give Science Learning Equal Priority as Other Core Subjects